Cargando…

Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates

Cardiometabolic diseases are associated with low-grade inflammation early in life and persists into old age. The long latency period presents opportunities for early detection, lifestyle modification and intervention. However, the performance of conventional biomarker assays to detect low-grade infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fung, Erik, Chan, Eunice Y. S., Ng, Kwan Hung, Yu, Ka Man, Li, Huijun, Wang, Yulan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563214/ https://www.ncbi.nlm.nih.gov/pubmed/37814278 http://dx.doi.org/10.1186/s12950-023-00358-7

Ejemplares similares

GlycA is not a useful biomarker of inflammation in sickle cell disease
por: Weisman, Julie K., et al.
Publicado: (2018)

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
por: Connelly, Margery A., et al.
Publicado: (2017)

GlycA: Evaluation of a New Biomarker of Acute Pancreatitis
por: Shah, Ishani, et al.
Publicado: (2023)

GlycA, a Biomarker of Low-Grade Inflammation, Is Increased in Male Night Shift Workers
por: Bizzarri, Daniele, et al.
Publicado: (2022)

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
por: Riggs, Kayla A., et al.
Publicado: (2022)

Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
por: Riggs, Kayla A., et al.
Publicado: (2019)

GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases()
por: Mehta, Nehal N., et al.
Publicado: (2020)

GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2020)

Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
por: Ormseth, Michelle J., et al.
Publicado: (2015)

Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes
por: Bartlett, David B., et al.
Publicado: (2017)

The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Jang, Sunyoung, et al.
Publicado: (2021)

Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
por: Assone, Tatiane, et al.
Publicado: (2022)

GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2015)

Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife
por: Cohen-Manheim, Irit, et al.
Publicado: (2015)

GlycA, a marker of protein glycosylation, is related to albuminuria and estimated glomerular filtration rate: the ELSA-Brasil study
por: Titan, Silvia M., et al.
Publicado: (2017)

Elevated serum alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality
por: Ritchie, Scott C., et al.
Publicado: (2019)

Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity
por: Dierckx, Tim, et al.
Publicado: (2020)

GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD
por: Dierckx, Tim, et al.
Publicado: (2019)

GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis
por: Gruppen, E. G., et al.
Publicado: (2019)

A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
por: Bartlett, David B., et al.
Publicado: (2016)

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children
por: Connelly, Margery A., et al.
Publicado: (2016)

The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
por: Puig-Jové, Carlos, et al.
Publicado: (2022)

GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile
por: Mokkala, Kati, et al.
Publicado: (2020)

A Dietitian-Led Vegan Program May Improve GlycA, and Other Novel and Traditional Cardiometabolic Risk Factors in Patients With Dyslipidemia: A Pilot Study
por: Chiu, Tina H. T., et al.
Publicado: (2022)

ProGlycProt: a repository of experimentally characterized prokaryotic glycoproteins
por: Bhat, Aadil H., et al.
Publicado: (2012)

Association Between Smoking and Serum GlycA and High‐Sensitivity C‐Reactive Protein Levels: The Multi‐Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil)
Publicado: (2017)

Association Between Smoking and Serum GlycA and High‐Sensitivity C‐Reactive Protein Levels: The Multi‐Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil)
por: Kianoush, Sina, et al.
Publicado: (2017)

O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease
por: Zhou, Yicheng, et al.
Publicado: (2022)

GlycReSoft: A Software Package for Automated Recognition of Glycans from LC/MS Data
por: Maxwell, Evan, et al.
Publicado: (2012)

The force effects of two types of polyethylene terephthalate glyc-olmodified clear aligners immersed in artificial saliva
por: Xiang, Biao, et al.
Publicado: (2021)

GlycCompSoft: Software for Automated Comparison of Low Molecular Weight Heparins Using Top-Down LC/MS Data
por: Wang, Xiaohua, et al.
Publicado: (2016)

Possible Treatment of Myocardial Infarct Based on Tissue Engineering Using a Cellularized Solid Collagen Scaffold Functionalized with Arg-Glyc-Asp (RGD) Peptide
por: Schussler, Olivier, et al.
Publicado: (2021)

Triaquabis{μ-N-[N-(4-methoxy-2-oxidobenzylidene)glycyl]glycinato(3−)}cadmium(II)dicopper(II) dihydrate
por: Jiang, Jiaxun, et al.
Publicado: (2009)

Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study
por: Dardari, Dured, et al.
Publicado: (2022)

Hepatocellular carcinoma: recent advances and emerging medical therapies
por: Ko, Kwan-Lung, et al.
Publicado: (2020)

The calcium-sensing receptor in inflammation: Recent updates
por: Iamartino, Luca, et al.
Publicado: (2022)

A randomized, double-blind clinical trial of a herbal formulation (GlycaCare-II) for the management of type 2 diabetes in comparison with metformin
por: Majeed, Muhammed, et al.
Publicado: (2021)

Acute-on-chronic liver failure: recent update
por: Alam, Azeem, et al.
Publicado: (2017)

Perioperative “remote” acute lung injury: recent update
por: Jin, Zhaosheng, et al.
Publicado: (2017)

Recent Updates of Lipoprotein(a) and Cardiovascular Disease
por: Liu, Taili, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_69hb7lucdrcb35b6ft7ijjb2gj